Tyrosine Kinase Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Chemotherapy PARP Inhibitors Serine-Threonine Kinase Inhibitors BCL Inhibitors | Ovarian Cancer |
---|---|
carboplatin + paclitaxel | |
nivolumab + ramucirumab | |
carboplatin + pegylated liposomal doxorubicin | |
bevacizumab | |
PARP inhibitor + mTORC1 inhibitor | |
PARP inhibitor + mTORC2 inhibitor | |
PARP inhibitor + AKT inhibitor |